You have 9 free searches left this month | to do more

trabectedin

Trabectedin is a drug used to treat Sarcoma, Soft Tissue Sarcoma, Leiomyosarcoma, and other conditions. Trabectedin is being actively studied in 13 studies and prior, has been studied in 38.

Top SponsorsTop SitesTop Investigators
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Institut BergonieEric Kampmann
Italian Sarcoma GroupCentre Leon BerardMarilyn Huang
European Organisation for Research and Treatment of Cancer - EORTCIstituto Clinico HumanitasMichele Reni
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
G
Completed
  • Uterine or Soft Tissue Leiomyosarcoma
  • Villejuif, Val De Marne, France
    Gustave Roussy
2021-12-10
Dec 10, 2021
U
Recruiting
  • Sarcoma
  • Sarcoma Metastatic
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
2021-12-15
Dec 15, 2021
I
Recruiting
  • Soft Tissue Sarcoma Adult
  • +6 more
  • Trabectedin
  • Bordeaux, France
    Institut Bergonie
2022-02-01
Feb 1, 2022
F
Completed
  • Carcinosarcoma, Ovarian
  • Carcinosarcomas Uterine
  • Trabectedin
  • Rome, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
2021-08-24
Aug 24, 2021
I
Active, not recruiting
  • Mesenchymal Chondrosarcoma
  • Trabectedin
  • Prato, Firenze, Italy
  • +5 more
2021-10-29
Oct 29, 2021
G
Recruiting
  • Soft Tissue Sarcoma
  • +2 more
  • Trabectedin
  • Barcelona, Cataluña, Spain
  • +6 more
2021-11-23
Nov 23, 2021
I
Recruiting
  • Solitary Fibrous Tumors
  • Trabectedin
  • +2 more
  • Prato, Firenze, Italy
  • +5 more
2021-10-29
Oct 29, 2021
I
Completed
  • Soft Tissue Sarcoma
  • Bone Tumor
  • Candiolo, Torino, Italy
  • +2 more
2021-04-13
Apr 13, 2021
M
Not yet recruiting
  • Liposarcoma, Myxoid
  • +2 more
  • Trabectedin
  • Pioglitazone Oral Product
  • (no location specified)
2021-03-10
Mar 10, 2021
F
Terminated
  • Metastatic Leiomyosarcoma
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2020-11-16
Nov 16, 2020
S
Recruiting
  • Advanced Soft Tissue Sarcoma
  • Metastatic Soft Tissue Sarcoma
  • Trabectedin
  • +2 more
  • Santa Monica, California
    Sarcoma Oncology Research Center
2021-05-05
May 5, 2021
I
Active, not recruiting
  • Leiomyosarcoma of Ovary
  • Soft Tissue Sarcoma
  • Trabectedin
  • +2 more
  • Bologna, BO, Italy
  • +12 more
2021-10-29
Oct 29, 2021
S
Recruiting
  • Leiomyosarcoma
  • Trabectedin
  • Santa Monica, California
    Sant P Chawla
2021-09-09
Sep 9, 2021
I
Completed
  • Liposarcoma
  • Leiomyosarcoma
  • Trabectedin
  • Bari, BA, Italy
  • +20 more
2021-10-29
Oct 29, 2021
C
Completed
  • Sarcoma
  • Trabectedin
  • (no location specified)
2020-05-15
May 15, 2020
U
Active, not recruiting
  • Metastatic Adult Soft Tissue Sarcoma
  • Bad Saarow, Germany
  • +8 more
2021-02-19
Feb 19, 2021
E
Terminated
  • Sarcoma, Soft Tissue
  • Trabectedin
  • Bordeaux, France
  • +13 more
2020-09-01
Sep 1, 2020
M
Withdrawn
  • Refractory Chronic Lymphocytic Leukemia
  • Refractory Small Lymphocytic Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
2020-03-11
Mar 11, 2020
N
Recruiting
  • Cancers With DNA Repair-Deficiency
  • Dresden, Germany
  • +8 more
2022-01-12
Jan 12, 2022
G
Unknown status
  • Liposarcoma, Myxoid
  • +4 more
  • Trabectedin
  • Radiotherapy
  • Bordeaux, France
  • +15 more
2020-04-27
Apr 27, 2020
M
Completed
  • Malignant Pleural Mesothelioma
  • Trabectedin
  • Alessandria, AL, Italy
  • +7 more
2020-01-22
Jan 22, 2020
F
Withdrawn
  • Myxoid Liposarcoma
  • +5 more
  • Biopsy
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2019-09-06
Sep 6, 2019
L
Recruiting
  • Sarcoma
  • Trabectedin
  • DNA double-strand breaks
  • Munich, Bavaria, Germany
  • +4 more
2019-07-11
Jul 11, 2019
P
Completed
  • Relapsed Ovarian Cancer
  • trabectedin
  • Aalst, Flandes, Belgium
  • +64 more
2021-09-30
Sep 30, 2021